Media Contact

social-linkedin social-youtube  social-facebook  social-twitter  social-instagram

LabMind podcasts

View Factsheet PDF

February 3, 2026

Rarity Bioscience Announces That ARUP Laboratories Has Become the First U.S. Reference Lab To Validate Its Ultrasensitive superRCA Assay

ARUP is the first U.S. lab to validate Rarity Bioscience’s ultrasensitive superRCA™ assay, which advances high-precision mutation detection and supports innovation in clinical and trial settings.

Magnify Logo

January 29, 2026

The Winter 2026 Edition of ARUP’s Magnify Magazine Is Now Available and Focuses on Pediatric Testing

ARUP has built a comprehensive pediatric test menu and paired it with research, education, and expert consultation to help care teams make informed decisions for children.

Kamisha Johnson-Davis in a lab

Kamisha Johnson-Davis, PhD, MBA, DABCC (CC, TC), ARUP medical director of Clinical Toxicology, contributed her expertise to the development of new guidance for emergency department drug testing. 

January 27, 2026

ARUP Medical Director Contributes to New ADLM Emergency Department Guidance for Drugs of Misuse

New ADLM guidance helps emergency department providers choose and interpret urine drug tests, highlighting current methods, limitations, and recommended drug classes.

Illustration of a yellow silhouette head on a background of blue silhouette heads. Red dots on the yellow silhouette reach out to the blue silhouettes.

January 26, 2026

ARUP Consult Highlights Specimen Self-Collection During National Cervical Cancer Awareness Month

During Cervical Cancer Awareness Month, ARUP Consult® highlights self-collected vaginal specimen testing as an FDA-approved, guideline-supported option to help address HPV screening barriers.

Illustration of a yellow silhouette head on a background of blue silhouette heads. Red dots on the yellow silhouette reach out to the blue silhouettes.

ARUP’s assay is the first commercially available reference test that both detects the measles virus and distinguishes between vaccine-related and wild-type strains of the virus.

January 23, 2026

Dual-Target Molecular Measles Virus Assay Aids Response to Ongoing Outbreaks

ARUP Laboratories’ dual-target molecular measles virus assay provides a highly sensitive, specific, and rapid assay to aid the public health response to ongoing measles outbreaks.

James Hadley sit in an office in front of windows with a view of foothills.

James Hadley, CISSP, joined ARUP as chief information security officer (CISO) in July 2025 after having served as CISO for the U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR).

January 7, 2026

Chief Information Security Officer Brings Vast Federal and Healthcare Experience to ARUP

James Hadley, CISSP, chief information security officer, brings 25 years of cybersecurity experience to ARUP with a focus on risk management, collaboration, and building a resilient security culture.

Media Contact

social-linkedin social-youtube  social-facebook  social-twitter  social-instagram